Publications

Found 61 results
Filters: First Letter Of Last Name is F  [Clear All Filters]
2015
Beltran H, Eng K, Mosquera JMiguel, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J et al..  2015.  Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. JAMA Oncol. 1(4):466-74.
Beltran H, Eng K, Mosquera JMiguel, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J et al..  2015.  Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. JAMA Oncol. 1(4):466-74.
2014
Diamond E, Riches J, Faltas B, Tagawa ST, Nanus DM.  2014.  Immunologics and chemotherapeutics for renal cell carcinoma. Semin Intervent Radiol. 31(1):91-7.
2013
Andrei M, Cramer SF, Kramer ZB, Zeidan A, Faltas B.  2013.  Adult primary pulmonary primitive neuroectodermal tumor: molecular features and translational opportunities. Cancer Biol Ther. 14(2):75-80.
Faltas B, Zeidan A, Gergis U.  2013.  Myelodysplastic syndromes: toward a risk-adapted treatment approach. Expert Rev Hematol. 6(5):611-24.
Zeidan AM, Faltas B, B Smith D, Gore S.  2013.  Myelodysplastic syndromes: what do hospitalists need to know? J Hosp Med. 8(6):351-7.
Zeidan A, Faltas B, Forde P, Subhawong A, Bello C, Bolaños-Meade J.  2013.  Sequential occurrence of a splenic marginal zone lymphoma, extranodal MALT lymphoma, and Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk. 13(4):496-8.
Zeidan A, Faltas B, Forde P, Subhawong A, Bello C, Bolaños-Meade J.  2013.  Sequential occurrence of a splenic marginal zone lymphoma, extranodal MALT lymphoma, and Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk. 13(4):496-8.
Zeidan A, Faltas B, Fricke W, Gore S, Ketterling R, Sham R.  2013.  Sustained remission in a patient with myelodysplastic syndrome and a complex karyotype after erythropoiesis-stimulating therapy followed by colonic T-cell lymphoblastic lymphoma. Leuk Lymphoma. 54(7):1534-7.
Zeidan A, Faltas B, Fricke W, Gore S, Ketterling R, Sham R.  2013.  Sustained remission in a patient with myelodysplastic syndrome and a complex karyotype after erythropoiesis-stimulating therapy followed by colonic T-cell lymphoblastic lymphoma. Leuk Lymphoma. 54(7):1534-7.